It is our belief that the efficacy of research and development in such diseases as HIV, cancer, infectious diseases and chronic debilitating diseases, which have either attained or almost reached pandemic proportions, is circumscribed and seriously limited by the current system of narrow specialization which is reflected throughout the entire system from research, through development, financing and commercialization.

We think that the traditional approaches have become obsolete. We want to take a different and more effective approach to find solutions for these devastating diseases by creating a novel inter-disciplinary overlay intended to enable different specialties to be focused on a particular disease. For example, HIV is being attacked by individual researchers in virology and immunology, genetics, transfusion medicine, pharmacology, energy medicine, preventive mechanisms, social studies, etc. We want to make it possible for all the different avenues to speak to each other across specialty lines.

Our vision includes supporting leading edge early stage medical research and access to that cutting edge research for people facing critical medical challenges to their health. To fulfill this initiative we have committed ten percent of our profits to the Innovative Medicine Foundation and other charitable organizations that support state of the art research and crisis care.